Morgan Stanley lowered the firm’s price target on Manhattan Associates (MANH) to $165 from $200 and keeps an Equal Weight rating on the shares. The firm expects year-over-year RPO growth to decelerate to the high-teens in FY26, which it views as likely to disappoint “high investor expectations.” The firm cites two “underappreciated headwinds,” namely drainage as contracts approach renewal and a weaker OMS renewal cohort.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MANH:
- Manhattan Associates price target raised to $240 from $230 at Truist
- Manhattan Associates price target lowered to $200 from $204 at Citi
- Manhattan Associates’ Strategic Transition and Historical Outperformance Justify Buy Rating
- Manhattan Associates price target lowered to $239 from $244 at Barclays